Healthcare / Medical Care FacilitiesJakarta
$980.00
+15.00 (+1.55%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $20.2B · quality 59.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$911.1B
P/E
25.6x
↑EV/EBITDA
14.3x
↑ROE
4.2%
↑Gross Margin
31.4%
↓Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+9.3%
FCF CAGR
-5.6%
FCF margin
8.4%
FCF / Net income
1.14x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $469.59B · net income $34.51B · FCF $39.44B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $469.59B | $469.59B | $441.07B | $373.40B | $359.16B |
| Net Income | $34.51B | $34.51B | $39.69B | $25.19B | $26.18B |
| EBITDA | $60.98B | $60.98B | $66.68B | $44.61B | $57.60B |
| EPS | 37.12 | 37.12 | 42.69 | 27.09 | 28.16 |
| Gross Margin | 31.4% | 31.4% | 33.9% | 33.0% | 36.7% |
| Operating Margin | 9.6% | 9.6% | 11.7% | 7.1% | 11.4% |
| Net Margin | 7.3% | 7.3% | 9.0% | 6.7% | 7.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | — | — | 0.00 |
| Current Ratio | 1.22 | 1.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $39.44B | $39.44B | $20.18B | $-6.03B | $46.95B |
| Returns | |||||
| ROE | 4.2% | 4.2% | 5.0% | 3.4% | 3.2% |
| Valuation | |||||
| P/E | 25.57 | 25.57 | 23.66 | 46.51 | 38.71 |
| EV/EBITDA | 14.28 | 14.28 | 13.27 | 24.97 | 14.59 |
| P/B | 1.10 | 1.10 | 1.18 | 1.56 | 1.24 |
| Growth & Yield | |||||
| Revenue Growth | 6.5% | 6.5% | 18.1% | 4.0% | — |
| EPS Growth | -13.0% | -13.0% | 57.6% | -3.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
32.8%
EPS terminal req.
$86.96
Spread vs growth
-45.9%
5Y implied EPS CAGR
23.2%
EPS terminal req.
$105.22
Spread vs growth
-36.2%
10Y implied EPS CAGR
16.4%
EPS terminal req.
$169.46
Spread vs growth
-29.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
23.0x → 26.4x
EPS bridge
42.69 → 37.12
Residual
-2.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.